These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11672929)

  • 41. TC-83 vaccine protects against airborne or subcutaneous challenge with heterologous mouse-virulent strains of Venezuelan equine encephalitis virus.
    Phillpotts RJ; Wright AJ
    Vaccine; 1999 Feb; 17(7-8):982-8. PubMed ID: 10067707
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A field study of persistence of antibodies in California horses vaccinated against western, eastern, and Venezuelan equine encephalomyelitis.
    Vanderwagen LC; Pearson JL; Franti CE; Tamm EL; Riemann HP; Behymer DE
    Am J Vet Res; 1975 Nov; 36(11):1567-71. PubMed ID: 1190598
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neutralizing antibody responses of humans and mice to vaccination with Venezuelan encephalitis (TC-83) virus.
    Fillis CA; Calisher CH
    J Clin Microbiol; 1979 Oct; 10(4):544-9. PubMed ID: 93607
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The immunity generated in white rats vaccinated with strains of the Venezuelan equine encephalomyelitis virus].
    Moshkov SP; Grabareva LP; Moshkov AE; Gaĭdamovich SIa
    Vopr Virusol; 1991; 36(5):417-9. PubMed ID: 1803778
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Venezuelan equine encephalitis vaccine with rearranged genome resists reversion and protects non-human primates from viremia after aerosol challenge.
    Tretyakova I; Plante KS; Rossi SL; Lawrence WS; Peel JE; Gudjohnsen S; Wang E; Mirchandani D; Tibbens A; Lamichhane TN; Lukashevich IS; Comer JE; Weaver SC; Pushko P
    Vaccine; 2020 Apr; 38(17):3378-3386. PubMed ID: 32085953
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In mice the efficiency of immunization with Venezuelan Equine Encephalomyelitis virus TC-83 is transiently increased by dehydroepiandrosterone.
    Negrette B; Bonilla E; Valero N; Giraldoth D; Medina-Leendertz S; Añez F
    Invest Clin; 2001 Dec; 42(4):235-40. PubMed ID: 11787268
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cross-protection in hamsters immunized with group A arbovirus vaccines.
    Cole FE; McKinney RW
    Infect Immun; 1971 Jul; 4(1):37-43. PubMed ID: 5154876
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Experimental infection of horses with an attenuated Venezuelan equine encephalomyelitis vaccine (strain TC-83).
    Walton TE; Alvarez O; Buckwalter RM; Johnson KM
    Infect Immun; 1972 May; 5(5):750-6. PubMed ID: 4637604
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetically engineered, live attenuated vaccines for Venezuelan equine encephalitis: testing in animal models.
    Pratt WD; Davis NL; Johnston RE; Smith JF
    Vaccine; 2003 Sep; 21(25-26):3854-62. PubMed ID: 12922119
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immune interference after sequential alphavirus vaccine vaccinations.
    Pittman PR; Liu CT; Cannon TL; Mangiafico JA; Gibbs PH
    Vaccine; 2009 Aug; 27(36):4879-82. PubMed ID: 19576665
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Early protection in hamsters immunized with attenuated Venezuelan equine encephalomyelitis vaccine.
    Cole FE; Pedersen CE; Robinson DM
    Appl Microbiol; 1972 Oct; 24(4):604-8. PubMed ID: 5086903
    [TBL] [Abstract][Full Text] [Related]  

  • 52. IRES-based Venezuelan equine encephalitis vaccine candidate elicits protective immunity in mice.
    Rossi SL; Guerbois M; Gorchakov R; Plante KS; Forrester NL; Weaver SC
    Virology; 2013 Mar; 437(2):81-8. PubMed ID: 23351391
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
    Nasar F; Matassov D; Seymour RL; Latham T; Gorchakov RV; Nowak RM; Leal G; Hamm S; Eldridge JH; Tesh RB; Clarke DK; Weaver SC
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148802
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of Venezuelan equine encephalitis virus subtype IE with two equine epizootics in Mexico.
    Oberste MS; Fraire M; Navarro R; Zepeda C; Zarate ML; Ludwig GV; Kondig JF; Weaver SC; Smith JF; Rico-Hesse R
    Am J Trop Med Hyg; 1998 Jul; 59(1):100-7. PubMed ID: 9684636
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation in humans of a new, inactivated vaccine for Venezuelan equine encephalitis virus (C-84).
    Edelman R; Ascher MS; Oster CN; Ramsburg HH; Cole FE; Eddy GA
    J Infect Dis; 1979 Nov; 140(5):708-15. PubMed ID: 528788
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intranasal immunisation with defective adenovirus serotype 5 expressing the Venezuelan equine encephalitis virus E2 glycoprotein protects against airborne challenge with virulent virus.
    Phillpotts RJ; O'brien L; Appleton RE; Carr S; Bennett A
    Vaccine; 2005 Feb; 23(13):1615-23. PubMed ID: 15694514
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Systemic, mucosal, and heterotypic immune induction in mice inoculated with Venezuelan equine encephalitis replicons expressing Norwalk virus-like particles.
    Harrington PR; Yount B; Johnston RE; Davis N; Moe C; Baric RS
    J Virol; 2002 Jan; 76(2):730-42. PubMed ID: 11752163
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Localization of a protective epitope on a Venezuelan equine encephalomyelitis (VEE) virus peptide that protects mice from both epizootic and enzootic VEE virus challenge and is immunogenic in horses.
    Hunt AR; Roehrig JT
    Vaccine; 1995 Feb; 13(3):281-8. PubMed ID: 7543231
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human transcriptome response to immunization with live-attenuated Venezuelan equine encephalitis virus vaccine (TC-83): Analysis of whole blood.
    Erwin-Cohen RA; Porter AI; Pittman PR; Rossi CA; DaSilva L
    Hum Vaccin Immunother; 2017 Jan; 13(1):169-179. PubMed ID: 27870591
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multiagent vaccines vectored by Venezuelan equine encephalitis virus replicon elicits immune responses to Marburg virus and protection against anthrax and botulinum neurotoxin in mice.
    Lee JS; Groebner JL; Hadjipanayis AG; Negley DL; Schmaljohn AL; Welkos SL; Smith LA; Smith JF
    Vaccine; 2006 Nov; 24(47-48):6886-92. PubMed ID: 16828936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.